Todd E. Golde

A benchmark for future disease-modifying therapies in Alzheimer’s disease

Testing anti-amyloid therapies in preclinical Alzheimer’s disease

Finding the ‘goldilocks’ zone for Alzheimer’s disease immunotherapies

Manipulation of the immune system for Alzheimer’s disease therapy

Immune activation states in Alzheimer’s disease mouse models